These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Current pharmacotherapy of Parkinson's disease].
    Author: Takáts A.
    Journal: Orv Hetil; 2000 Mar 05; 141(10):483-8. PubMed ID: 10750400.
    Abstract:
    Parkinson's disease (PD) is one of the most common neurodegenerative disorders. The morbidity is about 1-2 of 1000 under 65 years, but it increases to 1-2 of 100 in the population over 65 years. PD became the model of degenerative disorders either concerning the etiopathogenesis or the therapeutic possibilities. Recently the therapy is focused mostly on pharmaceutics, although the treatment of PD is complex. The new drugs improve the quality of life, and there is some evidence that some of them may slow down the progression of the disease. These drugs may provide a neuroprotective therapy, and so a better life expectancy.
    [Abstract] [Full Text] [Related] [New Search]